High Myeloid-Related Protein
Authors:
- Louise M. CatanzaritiLCLouise M. Catanzariti
- Michiel L. BotsMBMichiel L. Bots
- Jean-Paul P.M. de VriesJVJean-Paul P.M. de Vries
- Frans L. MollFMFrans L. Moll
- Siu Kwan SzeSSSiu Kwan Sze
- Gerard PasterkampGPGerard Pasterkamp
- Dominique P.V. de KleijnDKDominique P.V. de Kleijn
- 1 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (9) , 2010-2015
Abstract
Background and Purpose— Myeloid-related protein (Mrp) 8/14 complex is the functional relevant form of Mrp-8 and Mrp-14. Mrp-8/14 complex is actively formed in the cytoplasm of circulating neutrophils and monocytes and then secreted. Plasma Mrp-8/14 complex is emerging as a new biomarker that may discriminate between patients with an acute coronary syndrome and those with stable coronary heart disease. Little is known about the predictive value of Mrp-8/14 plaque and plasma levels for cardiovascular events after atherectomy. Methods and Results— Plasma and plaque Mrp-8/14 levels were determined by ELISA in 230 consecutive patients (mean age 73) who underwent carotid endarterectomy. Patients were followed for 3 years for recurrent cardiovascular events (vascular death, nonfatal vascular event, and peripheral intervention). During follow-up, 62 patients experienced an event. Baseline Mrp-8/14 levels were higher in patients who experienced an event than in event-free patients (plasma 0.78±0.63 versus 0.57±0.67 mg/L; P =0.030 and plaque 0.54±1.23 versus 0.08±1.51 mg/kg; P =0.027). In a Cox model, a 1 U increase in log Mrp-8/14 was associated with an increased risk of recurrent events (plasma, hazard ratio [HR], 1.51; 95% CI, 1.02 to 2.23, P =0.040; and plaque, HR, 1.23, 95% CI, 1.04 to 1.46, P =0.018). After multivariate adjustment for risk factors (both plasma and plaque Mrp-8/14) and plaque characteristics (only plaque Mrp-8/14), the HR remained the same for both plasma (HR, 1.50, 95% CI, 1.01 to 2.30; P =0.046) and plaque (HR, 1.20, 95% CI, 1.01 to 1.44; P =0.042). Conclusion— High Mrp-8/14 plasma and plaque levels are related to an increased risk of adverse cardiovascular events after a carotid endarterectomy, independent of traditional cardiovascular risk factors.Keywords
This publication has 15 references indexed in Scilit:
- Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular InjuryCirculation, 2009
- High Levels of Myeloid-Related Protein 14 in Human Atherosclerotic Plaques Correlate With the Characteristics of Rupture-Prone LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Carotid Atherosclerotic Plaques Stabilize After StrokeArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trialAmerican Heart Journal, 2008
- Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromesEuropean Heart Journal, 2007
- Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular EventsCirculation, 2006
- Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritisArthritis & Rheumatism, 2004
- Athero-express: Differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and designEuropean Journal of Epidemiology, 2004
- S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunityMicroscopy Research and Technique, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003